Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-11

FDA Approved: KYZATREX — Supplemental Application (Marius Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for KYZATREX (testosterone undecanoate) by Marius Pharmaceuticals. The action updates the existing approval for this…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KYZATREX (Testosterone undecanoate)

Snippet

SUPPL AP for KYZATREX (TESTOSTERONE UNDECANOATE)